Stifel Canada Issues Optimistic Outlook for QIPT Earnings

Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) - Analysts at Stifel Canada upped their Q2 2025 EPS estimates for Quipt Home Medical in a research note issued on Tuesday, February 11th. Stifel Canada analyst J. Keywood now expects that the company will post earnings of $0.02 per share for the quarter, up from their previous estimate of $0.01. The consensus estimate for Quipt Home Medical's current full-year earnings is ($0.05) per share. Stifel Canada also issued estimates for Quipt Home Medical's Q3 2025 earnings at $0.03 EPS.

Quipt Home Medical Price Performance

Shares of QIPT traded down $0.27 during mid-day trading on Friday, reaching $2.70. The stock had a trading volume of 151,349 shares, compared to its average volume of 157,914. The firm has a market cap of $116.34 million, a price-to-earnings ratio of -18.00 and a beta of 0.57. Quipt Home Medical has a 12 month low of $2.30 and a 12 month high of $4.58. The business has a fifty day moving average of $2.90 and a 200 day moving average of $2.82. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.86 and a current ratio of 1.20.

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last issued its quarterly earnings results on Monday, February 10th. The company reported ($0.03) earnings per share for the quarter. Quipt Home Medical had a negative net margin of 2.66% and a negative return on equity of 6.18%.

Insiders Place Their Bets

In other news, VP Patrick Dennis Gamble purchased 17,000 shares of the company's stock in a transaction on Thursday, December 26th. The stock was acquired at an average cost of $2.45 per share, for a total transaction of $41,650.00. Following the completion of the transaction, the vice president now directly owns 40,057 shares in the company, valued at $98,139.65. This trade represents a 73.73 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 13.40% of the company's stock.

Hedge Funds Weigh In On Quipt Home Medical

Hedge funds and other institutional investors have recently modified their holdings of the stock. Forager Capital Management LLC boosted its position in shares of Quipt Home Medical by 77.7% during the third quarter. Forager Capital Management LLC now owns 4,192,562 shares of the company's stock worth $12,200,000 after acquiring an additional 1,833,590 shares during the last quarter. Kanen Wealth Management LLC purchased a new stake in shares of Quipt Home Medical in the fourth quarter valued at $4,346,000. Royce & Associates LP raised its stake in shares of Quipt Home Medical by 15.8% in the third quarter. Royce & Associates LP now owns 1,768,789 shares of the company's stock valued at $5,165,000 after acquiring an additional 240,980 shares during the period. State Street Corp raised its stake in shares of Quipt Home Medical by 1.0% in the third quarter. State Street Corp now owns 621,388 shares of the company's stock valued at $1,814,000 after acquiring an additional 6,317 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in shares of Quipt Home Medical by 68.7% in the third quarter. JPMorgan Chase & Co. now owns 30,403 shares of the company's stock valued at $89,000 after acquiring an additional 12,383 shares during the period. Institutional investors own 42.85% of the company's stock.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.